세계의 생검 기기 시장 : 제품별, 용도별, 가이드별, 최종사용자별, 지역별 - 예측(-2028년)

Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy), Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy), Guidance (Stereotactic, Ultrasound), End User (Hospital) & Region - Global Forecast to 2028

US $ 4,950 ￦ 6,802,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,138,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,199,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,742,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 생검 기기 시장 규모는 2023년 66억 달러, 2028년까지 126억 달러에 달하고, 2023-2028년간 연평균 복합 성장률(CAGR) 14.0%로 성장할 것으로 예상됩니다.

암 및 기타 만성 질환의 발병률 증가와 같은 요인으로 인해 보다 빈번하고 정확한 조직 샘플링의 필요성이 증가하고 있습니다. 또한, 질병의 조기 발견과 개인 맞춤형 의료의 중요성에 대한 인식이 높아지면서 첨단 생검 기기에 대한 수요가 증가하고 있습니다.

"제품 부문에서는 바늘 생검 기기 부문이 2022년 시장에서 가장 큰 점유율을 차지했습니다. "

바늘 생검 기기가 시장에서 큰 비중을 차지하고 있습니다. 바늘 생검 기술의 발전, 예를 들어 가이드 시스템의 개선 및 조직 유형에 따라 보다 특수한 바늘의 개발은 이러한 절차의 정확성과 신뢰성을 향상시켜 그 보급을 더욱 촉진하고 있습니다.

"유방 생검 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.

유방암은 여전히 세계적으로 가장 많이 발생하는 암 중 하나이며, 조기 정확한 진단의 중요성이 강조되고 있습니다. 유방암에 대한 인식과 검진 프로그램이 확대됨에 따라 진단을 확정하고 치료 전략을 결정하기 위한 생검에 대한 수요가 증가하고 있습니다.

"최종 사용자 부문에서는 영상 진단센터 부문이 예측 기간 동안 높은 CAGR을 기록할 것으로 예상됩니다. "

이미징 센터 부문은 2022년 시장에서 큰 점유율을 차지할 것으로 예상됩니다. 영상 진단센터는 첨단 생검 기기를 통해 보다 정확하고 신뢰할 수 있는 진단을 제공함으로써 더 나은 치료 계획과 환자 결과 개선에 도움을 줄 수 있습니다. 또한, 영상진단센터는 생검 기기의 다재다능함을 통해 다양한 진료과목에 대응할 수 있어 다양한 의료 수요를 가진 환자들에게 효과적으로 서비스를 제공할 수 있습니다.

"북미 시장은 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다. "

이것은 주로 이 지역의 높은 의료비 지출, 대상 질환의 유병률 증가, 연구 활동 증가, 미용 수술 증가, 영상 시스템 기술의 발전에 기인합니다.

이 보고서는 세계 생검 기기(Biopsy Devices) 시장에 대해 조사 분석했으며, 주요 촉진요인과 억제요인, 경쟁 구도, 향후 동향 등의 정보를 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

• 생검 기기 시장 개요
• 북미 생검 기기 시장 : 제품별(2023년·2028년)
• 아시아태평양의 생검 기기 시장 : 최종사용자별(2023년·2028년)
• 유럽의 생검 기기 시장 : 가이드 기술별(2023년·2028년)
• 생검 기기 시장 : 지역적인 성장 기회

제5장 시장 개요

• 서론
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• Porter의 Five Forces 분석
• 규제 분석
  • 규제기관, 정부기관, 기타 조직
  • 생검 기기 시장 규제 동향
• 상환 시나리오 분석
• 에코시스템/시장 맵
• 밸류체인 분석
  • 연구, 제품 개발
  • 원재료 조달과 제조
  • 출하, 마케팅과 판매, 판매 후 서비스
• 공급망 분석
  • 대기업
  • 중소기업
  • 최종사용자
• 특허 분석
• 무역 분석
• 주요 이해관계자와 구입 기준
• 주요 컨퍼런스 및 이벤트(2023년-2025년)
• 기술 분석
• 사례 연구 분석
• 가격 분석

제6장 생검 기기 시장 : 제품별

• 서론
• 액체생검 기구
• 바늘 기반 생검 기구
  • 코어 생검 기기
  • 흡인 생검침
  • 진공 보조 생검 기기
• 수술용 트레이
• 위치 특정 와이어
• 생검대
• 생검 겸자
  • 일반적인 생검 겸자
  • 핫 생검 겸자
• 기타 제품

제7장 생검 기기 시장 : 가이드 기술별

• 서론
• 비영상 가이드하 생검
• 영상 가이드하 생검
  • 초음파 가이드하 생검
  • 스테레오 가이드 생검
  • MRI 가이드하 생검
  • 기타 영상 가이드하 생검 기술

제8장 생검 기기 시장 : 용도별

• 서론
• 폐암
• 유방암
• 대장암
• 신장암
• 전립선암
• 골수 생검
• 기타 용도

제9장 생검 기기 시장 : 최종사용자별

• 서론
• 병원 및 유방 케어 센터
• 영상 진단센터
• 학술기관 및 연구기관
• 기타 최종사용자

제10장 생검 기기 시장 : 지역별

• 서론
• 북미
  • 경기후퇴의 영향
  • 미국
  • 캐나다
• 유럽
  • 경기후퇴의 영향
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 경기후퇴의 영향
  • 중국
  • 일본
  • 인도
  • 호주
  • 한국
  • 기타 아시아태평양
• 라틴아메리카
  • 경기후퇴의 영향
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
• 중동 및 아프리카

제11장 경쟁 구도

• 개요
• 주요 기업의 전략
• 매출 점유율 분석
• 시장 점유율 분석
  • 바늘 기반 생검 기기 시장
  • 액체생검 시장
• 주요 기업 평가 매트릭스(2022년)
• 스타트업/중소기업 평가 매트릭스(2022년)
• 경쟁 시나리오와 동향

제12장 기업 개요

• 주요 기업
  • BECTON, DICKINSON AND COMPANY
  • DEVICOR MEDICAL PRODUCTS, INC.(PART OF DANAHER CORPORATION)
  • B. BRAUN MELSUNGEN AG
  • CARDINAL HEALTH, INC.
  • HOLOGIC, INC.
  • OLYMPUS CORPORATION
  • BOSTON SCIENTIFIC CORPORATION
  • FUJIFILM CORPORATION
  • MEDTRONIC PLC
  • STRYKER CORPORATION
  • COOK GROUP INCORPORATED
  • ARGON MEDICAL DEVICES
  • INRAD, INC.
  • CONMED CORPORATION
  • TELEFLEX INCORPORATED
  • QIAGEN N.V.
  • THERMO FISHER SCIENTIFIC, INC.
• 기타 기업
  • SUMMIT MEDICAL LLC
  • HILL-ROM HOLDINGS, INC.
  • GALLINI S.R.L
  • TRANSMED7, LLC
  • TSK LABORATORY INTERNATIONAL
  • MERIT MEDICAL SYSTEMS, INC.
  • DR. JAPAN CO., LTD.
  • IZI MEDICAL PRODUCTS
  • PLANMED OY
  • ADVIN HEALTH CARE
  • F. HOFFMANN-LA ROCHE LTD.
  • BIO-RAD LABORATORIES, INC.
  • ILLUMINA, INC.

제13장 부록

LSH

영문 목차

영문목차

The global biopsy devices market is projected to reach USD 12.6 billion by 2028 from USD 6.6 billion in 2023, at a CAGR of 14.0% from 2023 to 2028. Factors such as the the rising incidence of cancer and other chronic diseases has spurred the need for more frequent and accurate tissue sampling. Moreover, increased awareness of the importance of early disease detection and personalized medicine has driven demand for advanced biopsy devices.

Scope of the Report
Years Considered for the Study	2021-2028
Base Year	2022
Forecast Period	2023-2028
Units Considered	Value (USD) Billion
Segments	Product, guidance technique, application, end user, and region
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The Needle based biopsy instruments segment of product segment l held the largest share of the market in 2022"

Based on product, the biopsy devices market is segmented into needle based biopsy instruments, localization wire, biopsy forceps, procedure tray, biopsy table and other products. The needle based biopsy instruments segment held a major share of the market. advancements in needle biopsy technologies, such as improved guidance systems and the development of more specialized needles for different tissue types, have increased the accuracy and reliability of these procedures, further driving their adoption.

"The breast biopsy segment is projected to register the highest CAGR during the forecast period"

Based on application, the biopsy devices market is segmented into breast, lung, kidney, colorectal, bone marrow, prostate and other applications. The breast biopsy segment accounted for the largest market share in 2022. breast cancer remains one of the most prevalent cancers globally, emphasizing the critical role of early and accurate diagnosis. As breast cancer awareness and screening programs expand, the demand for biopsy procedures to confirm diagnoses and determine treatment strategies is on the rise.

"The diagnostic imaging centers segment for end user segment is projected to register a significant CAGR during the forecast period"

On the basis of end user, the biopsy devices market is segmented into hospitals and breast care centers, diagnostic imaging cneters, academic and research institutes. The diagnostic imaging centers segment accounted for the significant share of the biopsy devices market in 2022. By advanced biopsy deives diagnostic imaging centers can provide more accurate and reliable diagnoses, leading to better treatment planning and improved patient outcomes. Moreover, the versatility of biopsy devices imaging enables these centers to cater to a wide range of medical specialties, effectively serving patients with diverse healthcare needs.

"The market in the North America region is expected to witness the highest growth during the forecast period."

The biopsy devices market in the North America region is expected to register a CAGR during the forecast period, primarily due to the high healthcare spending in the region, rising prevalence of target diseases, increasing research activities, growing number of cosmetic surgeries, and technological advancements in imaging systems.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
• By Designation: Director-level-14%, C-level-10%, and Others-76%
• By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

The prominent players in the biopsy devices market are Becton, Dickinson and Company (US), Cook Group Incorporated (US), Devicor Medical Products, Inc., (Leica Biosystems) (US), Hologic, Inc. (US), Argon Medical Devices (US), B. Braun SE (Germany), Cardinal Health, Inc. (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (US), and Medtronic plc (Ireland) among others.

Research Coverage

This report studies the biopsy devices market based on technology, display, portability, component, application, enduser, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall biopsy devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

• Analysis of key drivers (rising target patient population, growing adoption of biopsy devices imaging devices, technological advancement, and increasing investment, funds, and grants by public-private organizations), restraints (high capital and operational cost, unfavorable regulatory guidelines), opportunities (improving healthcare infrastructure across emerging countries, biopsy devices utilization for breast imaging, promising product pipeline), and challenges (availability of alternate imaging technologies) influencing the growth of the biopsy devices market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the biopsy devices market
• Market Development: Comprehensive information about lucrative markets-the report analyses the biopsy devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biopsy devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Becton, Dickinson and Company (US), Cook Group Incorporated (US), Devicor Medical Products, Inc., (Leica Biosystems) (US), Hologic, Inc. (US), Argon Medical Devices (US), B. Braun SE (Germany), Cardinal Health, Inc. (US), Olympus Corporation (Japan), and Boston Scientific Corporation (US) among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.2.2 MARKET SEGMENTATION
  • 1.2.3 YEARS CONSIDERED
  • 1.2.4 CURRENCY CONSIDERED
• 1.3 STAKEHOLDERS
• 1.4 SUMMARY OF CHANGES
• 1.5 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY RESEARCH
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Breakdown of primaries
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• 2.2 MARKET SIZE ESTIMATION METHODOLOGY
  • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
  • FIGURE 5 MARKET SIZE ESTIMATION FOR NEEDLE-BASED BIOPSY DEVICES AND ACCESSORY MARKET
  • FIGURE 6 MARKET SIZE ESTIMATION FOR LIQUID BIOPSY APPROACH 1 (COMPANY REVENUE ESTIMATION)
  • FIGURE 7 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF BECTON, DICKINSON, AND COMPANY
    • 2.2.1.2 Approach 2: Customer-based market estimation
    • 2.2.1.3 Top-down approach of biopsy devices market
    • 2.2.1.4 Approach 3: CAGR projections
  • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • 2.2.2 END USER-BASED MARKET SIZE ESTIMATION
  • FIGURE 9 BIOPSY DEVICES MARKET: END USER-BASED ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.3.1 MARKET SHARE ASSESSMENT
• 2.4 RESEARCH ASSUMPTIONS
• 2.5 GROWTH RATE ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 SCOPE-RELATED LIMITATIONS
  • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT
  • 2.7.1 RISK ASSESSMENT ANALYSIS
• 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 11 BIOPSY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
• FIGURE 12 BIOPSY DEVICES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 13 BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 14 GEOGRAPHICAL SNAPSHOT: BIOPSY DEVICES MARKET

4 PREMIUM INSIGHTS

• 4.1 BIOPSY DEVICES MARKET OVERVIEW
  • FIGURE 15 GROWING DEMAND FOR MINIMALLY INVASIVE SURGERY TO DRIVE MARKET
• 4.2 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
  • FIGURE 16 LIQUID BIOPSY INSTRUMENTS TO DOMINATE NORTH AMERICAN MARKET IN 2023
• 4.3 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
  • FIGURE 17 HOSPITALS & BREAST CARE CENTERS TO DOMINATE ASIA PACIFIC MARKET IN 2023
• 4.4 EUROPE: BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2023 VS. 2028 (USD MILLION)
  • FIGURE 18 NON-IMAGE-GUIDED BIOPSY SEGMENT TO DOMINATE EUROPEAN MARKET DURING FORECAST PERIOD
• 4.5 BIOPSY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 19 US TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: BIOPSY DEVICES MARKET
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of cancer
    • 5.2.1.2 Increasing preference for minimally invasive surgeries
    • 5.2.1.3 Initiatives undertaken by governments and global health organizations
    • 5.2.1.4 Increased number of hospitals and diagnostic centers
    • 5.2.1.5 Improved reimbursement scenario
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Increasing product recalls
  • TABLE 1 INDICATIVE LIST OF FDA PRODUCT RECALLS FOR BIOPSY DEVICES (2020-2021)
    • 5.2.2.2 High risk of infections for patients
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Technological innovations in biopsy devices
    • 5.2.3.2 Growing investments in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Underdeveloped healthcare infrastructure in emerging economies
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 2 PORTER'S FIVE FORCES ANALYSIS: BIOPSY DEVICES MARKET
  • 5.3.1 THREAT OF NEW ENTRANTS
  • 5.3.2 THREAT OF SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 REGULATORY ANALYSIS
  • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.4.1.1 North America
      • 5.4.1.1.1 US
  • TABLE 3 BIOPSY DEVICES UNDER 21 CFR 876.1075 WITH PRODUCT CODES
    • 5.4.1.2 Europe
  • FIGURE 21 EUROPE: CE MARK APPROVAL PROCESS FOR BIOPSY DEVICES
    • 5.4.1.3 Asia Pacific
      • 5.4.1.3.1 Japan
  • TABLE 4 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES
  • TABLE 5 NOMENCLATURE OF APPLICABLE MEDICAL DEVICES WITH CODES
    • 5.4.1.3.2 China
    • 5.4.1.3.3 India
  • TABLE 6 INDIA: REGULATORY CLASSIFICATION FOR MEDICAL DEVICES
    • 5.4.1.4 Latin America
      • 5.4.1.4.1 Brazil
  • FIGURE 22 BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES
  • TABLE 7 BRAZIL: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.4.1.4.2 Mexico
  • FIGURE 23 MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES
  • TABLE 8 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • 5.4.2 REGULATORY TRENDS FOR BIOPSY DEVICES MARKET
• 5.5 REIMBURSEMENT SCENARIO ANALYSIS
  • TABLE 9 MEDICAL REIMBURSEMENT CPT CODES FOR BIOPSY DEVICE PROCEDURES IN US (2021)
• 5.6 ECOSYSTEM/MARKET MAP
• 5.7 VALUE CHAIN ANALYSIS
  • 5.7.1 RESEARCH & PRODUCT DEVELOPMENT
  • 5.7.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
  • 5.7.3 SHIPMENT, MARKETING & SALES, AND POST-SALES SERVICES
  • FIGURE 24 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
• 5.8 SUPPLY CHAIN ANALYSIS
  • 5.8.1 PROMINENT COMPANIES
  • 5.8.2 SMALL AND MEDIUM-SIZED ENTERPRISES
  • 5.8.3 END USERS
  • TABLE 10 ROLE IN ECOSYSTEM: BIOPSY DEVICES MARKET
  • FIGURE 25 SUPPLY CHAIN ANALYSIS: BIOPSY DEVICES MARKET
• 5.9 PATENT ANALYSIS
  • FIGURE 26 PATENT DETAILS FOR NEEDLE-BASED BIOPSY INSTRUMENTS (JANUARY 2013-AUGUST 2023)
  • FIGURE 27 PATENTS FOR BIOPSY LOCALIZATION WIRES (JANUARY 2013-AUGUST 2023)
  • FIGURE 28 PATENTS FOR BIOPSY FORCEPS (JANUARY 2013-AUGUST 2023)
• 5.10 TRADE ANALYSIS
  • TABLE 11 IMPORT DATA FOR BIOPSY DEVICES (HS CODE 901839), BY COUNTRY, 2018-2022 (USD)
  • TABLE 12 EXPORT DATA FOR BIOPSY DEVICES (HS CODE 901839), BY COUNTRY, 2018-2022 (USD)
• 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.11.1 KEY STAKEHOLDERS IN BIOPSY DEVICES MARKET
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOPSY DEVICES
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOPSY DEVICES
  • 5.11.2 BUYING CRITERIA FOR BIOPSY DEVICES
  • FIGURE 30 KEY BUYING CRITERIA FOR BIOPSY DEVICES
  • TABLE 14 KEY BUYING CRITERIA FOR BIOPSY DEVICES
• 5.12 KEY CONFERENCES & EVENTS (2023-2025)
  • TABLE 15 LIST OF KEY CONFERENCES & EVENTS, 2023-2025
• 5.13 TECHNOLOGY ANALYSIS
• 5.14 CASE STUDY ANALYSIS
  • TABLE 16 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
  • TABLE 17 CASE STUDY 2: PROVIDING COMPREHENSIVE TRAINING PROGRAMS FOR EVOLVING BIOPSY TECHNIQUES
• 5.15 PRICING ANALYSIS
  • TABLE 18 REGION-WISE PRICE RANGE FOR BIOPSY DEVICES INSTRUMENTS, 2023

6 BIOPSY DEVICES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 19 BIOPSY DEVICES MARKET, BY PRODUCT TYPE, 2021-2028 (USD MILLION)
• 6.2 LIQUID BIOPSY INSTRUMENTS
  • 6.2.1 ONGOING RESEARCH AND CLINICAL TRIALS TO DELIVER NOVEL SOLUTIONS IN MARKET
  • TABLE 20 LIQUID BIOPSY INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 21 LIQUID BIOPSY INSTRUMENTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 22 LIQUID BIOPSY INSTRUMENTS MARKET, BY END USER, 2021-2028 (USD MILLION)
• 6.3 NEEDLE-BASED BIOPSY INSTRUMENTS
  • TABLE 23 NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 24 NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 25 NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 26 NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 6.3.1 CORE BIOPSY DEVICES
  • TABLE 27 CORE BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 28 CORE BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.1.1 Core biopsy needles
      • 6.3.1.1.1 Greater diagnostic accuracy and improved imaging capabilities to boost demand
  • TABLE 29 CORE BIOPSY NEEDLES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.1.2 Core biopsy guns
      • 6.3.1.2.1 Rapidity, efficiency, and accuracy to support adoption
  • TABLE 30 CORE BIOPSY GUNS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.2 ASPIRATION BIOPSY NEEDLES
    • 6.3.2.1 Innovations in needle design, including thinner profiles and improved tip configurations, to drive market
  • TABLE 31 ASPIRATION BIOPSY NEEDLES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.3 VACUUM-ASSISTED BIOPSY DEVICES
  • TABLE 32 VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 33 VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.3.1 Vacuum-assisted biopsy systems
      • 6.3.3.1.1 Increasing demand for early and accurate cancer detection, particularly in breast cancer, to drive market
  • TABLE 34 VACUUM-ASSISTED BIOPSY SYSTEMS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.3.2 Vacuum-assisted biopsy needles
      • 6.3.3.2.1 Innovative design and ability to retrieve larger specimens to support adoption
  • TABLE 35 VACUUM-ASSISTED BIOPSY NEEDLES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.4 PROCEDURE TRAYS
  • 6.4.1 DEMAND FOR EARLY CANCER DETECTION AND MINIMALLY INVASIVE TECHNIQUES TO DRIVE MARKET
  • TABLE 36 PROCEDURE TRAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 37 PROCEDURE TRAYS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 38 PROCEDURE TRAYS MARKET, BY END USER, 2021-2028 (USD MILLION)
• 6.5 LOCALIZATION WIRES
  • 6.5.1 ABILITY TO DETECT PRECISE TARGET LOCATIONS TO DRIVE MARKET
  • TABLE 39 LOCALIZATION WIRES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 40 LOCALIZATION WIRES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 41 LOCALIZATION WIRES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 6.6 BIOPSY TABLES
  • 6.6.1 EASE OF POSITIONING TO DRIVE DEMAND FOR BIOPSY TABLES
  • TABLE 42 BIOPSY TABLES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 43 BIOPSY TABLES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 44 BIOPSY TABLES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 6.7 BIOPSY FORCEPS
  • TABLE 45 BIOPSY FORCEPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 46 BIOPSY FORCEPS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 47 BIOPSY FORCEPS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 48 BIOPSY FORCEPS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 6.7.1 GENERAL BIOPSY FORCEPS
    • 6.7.1.1 Demand for minimally invasive procedures and precise diagnostics continues to surge market growth
  • TABLE 49 GENERAL BIOPSY FORCEPS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.7.2 HOT BIOPSY FORCEPS
    • 6.7.2.1 Unique ability to cut and coagulate tissue simultaneously to support adoption
  • TABLE 50 HOT BIOPSY FORCEPS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.8 OTHER PRODUCTS
  • TABLE 51 OTHER BIOPSY PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 52 OTHER BIOPSY PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 53 OTHER BIOPSY PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)

7 BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE

• 7.1 INTRODUCTION
  • TABLE 54 BIOPSY DEVICES MARKET, BY GUIDANCE TECHNIQUE, 2021-2028 (USD MILLION)
• 7.2 NON-IMAGE-GUIDED BIOPSY
  • 7.2.1 WIDE USAGE IN SITUATIONS WHERE IMAGING TECHNOLOGY IS INACCESSIBLE TO DRIVE MARKET
  • TABLE 55 NON-IMAGE-GUIDED BIOPSY MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.3 IMAGE-GUIDED BIOPSY
  • TABLE 56 IMAGE-GUIDED BIOPSY MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 57 IMAGE-GUIDED BIOPSY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3.1 ULTRASOUND-GUIDED BIOPSY
    • 7.3.1.1 Advantages of technique to boost usage
  • TABLE 58 ULTRASOUND-GUIDED BIOPSY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3.2 STEREOTACTIC-GUIDED BIOPSY
    • 7.3.2.1 Efficiency and accuracy to support adoption
  • TABLE 59 STEREOTACTIC-GUIDED BIOPSY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3.3 MRI-GUIDED BIOPSY
    • 7.3.3.1 High cost and low specificity to affect demand
  • TABLE 60 MRI-GUIDED BIOPSY MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3.4 OTHER IMAGE-GUIDED BIOPSY TECHNIQUES
  • TABLE 61 OTHER IMAGE-GUIDED BIOPSY TECHNIQUES MARKET, BY REGION, 2021-2028 (USD MILLION)

8 BIOPSY DEVICES MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • TABLE 62 BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 8.2 LUNG CANCER
  • 8.2.1 LUNG CANCER TO HOLD LARGEST MARKET SHARE
  • TABLE 63 BIOPSY DEVICES MARKET FOR LUNG CANCER, BY REGION, 2021-2028 (USD MILLION)
• 8.3 BREAST CANCER
  • 8.3.1 INCREASING DEMAND FOR EARLY AND ACCURATE DIAGNOSIS AND RISING PREVALENCE TO DRIVE MARKET
  • TABLE 64 BIOPSY DEVICES MARKET FOR BREAST CANCER, BY REGION, 2021-2028 (USD MILLION)
• 8.4 COLORECTAL CANCER
  • 8.4.1 RISING EMPHASIS ON EARLY DETECTION AND SCREENING TO SUPPORT MARKET GROWTH
  • TABLE 65 BIOPSY DEVICES MARKET FOR COLORECTAL CANCER, BY REGION, 2021-2028 (USD MILLION)
• 8.5 KIDNEY CANCER
  • 8.5.1 ADVANCEMENTS IN DIAGNOSTICS AND GROWING EMPHASIS ON CANCER THERAPEUTICS TO DRIVE MARKET
  • TABLE 66 BIOPSY DEVICES MARKET FOR KIDNEY CANCER, BY REGION, 2021-2028 (USD MILLION)
• 8.6 PROSTATE CANCER
  • 8.6.1 RISING INCIDENCE OF PROSTATE CANCER AND GROWING AGING POPULATION TO SUPPORT DEMAND FOR BIOPSY DEVICES
  • TABLE 67 BIOPSY DEVICES MARKET FOR PROSTATE CANCER, BY REGION, 2021-2028 (USD MILLION)
• 8.7 BONE MARROW BIOPSY
  • 8.7.1 RISING EMPHASIS ON BONE MARROW BIOPSIES TO SUPPORT MARKET GROWTH
  • TABLE 68 BIOPSY DEVICES MARKET FOR BONE MARROW BIOPSY, BY REGION, 2021-2028 (USD MILLION)
• 8.8 OTHER APPLICATIONS
  • TABLE 69 BIOPSY DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

9 BIOPSY DEVICES MARKET, BY END USER

• 9.1 INTRODUCTION
  • TABLE 70 BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.2 HOSPITALS & BREAST CARE CENTERS
  • 9.2.1 HIGH PROCEDURAL VOLUMES TO ENSURE SUSTAINED DEMAND FOR BIOPSY DEVICES
  • TABLE 71 BIOPSY DEVICES MARKET FOR HOSPITALS & BREAST CARE CENTERS, BY REGION, 2021-2028 (USD MILLION)
• 9.3 DIAGNOSTIC IMAGING CENTERS
  • 9.3.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO SUPPORT MARKET GROWTH
  • TABLE 72 BIOPSY DEVICES MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2021-2028 (USD MILLION)
• 9.4 ACADEMIC & RESEARCH INSTITUTES
  • 9.4.1 GROWING AVAILABILITY OF RESEARCH GRANTS AND FUNDING TO DRIVE MARKET
  • TABLE 73 BIOPSY DEVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
• 9.5 OTHER END USERS
  • TABLE 74 BIOPSY DEVICES MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

10 BIOPSY DEVICES MARKET, BY REGION

• 10.1 INTRODUCTION
  • TABLE 75 BIOPSY DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
• 10.2 NORTH AMERICA
  • 10.2.1 RECESSION IMPACT
  • FIGURE 31 NORTH AMERICA: BIOPSY DEVICES MARKET SNAPSHOT
  • TABLE 76 NORTH AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 77 NORTH AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 78 NORTH AMERICA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 79 NORTH AMERICA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 80 NORTH AMERICA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 81 NORTH AMERICA: BIOPSY FORCEPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 82 NORTH AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 83 NORTH AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2.2 US
    • 10.2.2.1 Rising geriatric population to drive market
  • TABLE 84 US: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.2.3 CANADA
    • 10.2.3.1 Government investments to support market growth
  • TABLE 85 CANADA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 10.3 EUROPE
  • 10.3.1 RECESSION IMPACT
  • TABLE 86 EUROPE: BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 87 EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 88 EUROPE: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 89 EUROPE: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 90 EUROPE: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 91 EUROPE: BIOPSY FORCEPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 92 EUROPE: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 93 EUROPE: BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3.2 GERMANY
    • 10.3.2.1 Increasing prevalence of chronic diseases to propel market
  • TABLE 94 GERMANY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.3.3 FRANCE
    • 10.3.3.1 Rising number of diagnostic imaging centers to drive market
  • TABLE 95 FRANCE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.3.4 UK
    • 10.3.4.1 Government initiatives to support market growth
  • TABLE 96 UK: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.3.5 ITALY
    • 10.3.5.1 Availability of reimbursement coverage to support market growth
  • TABLE 97 ITALY: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.3.6 SPAIN
    • 10.3.6.1 Increasing focus on cancer research to propel market
  • TABLE 98 SPAIN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.3.7 REST OF EUROPE
  • TABLE 99 REST OF EUROPE: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 10.4 ASIA PACIFIC
  • 10.4.1 RECESSION IMPACT
  • FIGURE 32 ASIA PACIFIC: BIOPSY DEVICES MARKET SNAPSHOT
  • TABLE 100 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 104 ASIA PACIFIC: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 105 ASIA PACIFIC: BIOPSY FORCEPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 106 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4.2 CHINA
    • 10.4.2.1 Rapidly growing geriatric population to propel market
  • TABLE 108 CHINA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.4.3 JAPAN
    • 10.4.3.1 High adoption of advanced technologies to support market growth
  • TABLE 109 JAPAN: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.4.4 INDIA
    • 10.4.4.1 Rising prevalence of chronic diseases to drive market
  • TABLE 110 INDIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Increasing investments in research to provide opportunities for market growth
  • TABLE 111 AUSTRALIA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Presence of well-developed healthcare system to propel market
  • TABLE 112 SOUTH KOREA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.4.7 REST OF ASIA PACIFIC
  • TABLE 113 REST OF ASIA PACIFIC: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 10.5 LATIN AMERICA
  • 10.5.1 RECESSION IMPACT
  • TABLE 114 LATIN AMERICA: BIOPSY DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 115 LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 116 LATIN AMERICA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 117 LATIN AMERICA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 118 LATIN AMERICA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 119 LATIN AMERICA: BIOPSY FORCEPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 120 LATIN AMERICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 121 LATIN AMERICA: BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5.2 BRAZIL
    • 10.5.2.1 Favorable demographic conditions to drive market
  • TABLE 122 BRAZIL: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.5.3 MEXICO
    • 10.5.3.1 Increased medical tourism and better government healthcare initiatives to drive market
  • TABLE 123 MEXICO: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • 10.5.4 REST OF LATIN AMERICA
  • TABLE 124 REST OF LATIN AMERICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET
  • 10.6.2 RECESSION IMPACT
  • TABLE 125 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 126 MIDDLE EAST & AFRICA: NEEDLE-BASED BIOPSY INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 127 MIDDLE EAST & AFRICA: CORE BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 128 MIDDLE EAST & AFRICA: VACUUM-ASSISTED BIOPSY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 129 MIDDLE EAST & AFRICA: BIOPSY FORCEPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 130 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 131 MIDDLE EAST & AFRICA: BIOPSY DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYERS STRATEGIES
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BIOPSY DEVICES MARKET
• 11.3 REVENUE SHARE ANALYSIS
  • FIGURE 33 TOP FIVE PLAYERS HAVE DOMINATED MARKET IN LAST FIVE YEARS
• 11.4 MARKET SHARE ANALYSIS
  • 11.4.1 NEEDLE-BASED BIOPSY DEVICES MARKET
  • FIGURE 34 MARKET SHARE ANALYSIS OF TOP PLAYERS IN BIOPSY DEVICES MARKET (2022)
  • TABLE 132 INTENSITY OF COMPETITIVE RIVALRY FOR NEEDLE-BASED DEVICES AND ACCESSORIES MARKET PLAYERS
  • 11.4.2 LIQUID BIOPSY MARKET
  • FIGURE 35 MARKET SHARE ANALYSIS OF TOP PLAYERS IN LIQUID BIOPSY MARKET (2022)
  • TABLE 133 INTENSITY OF COMPETITIVE RIVALRY FOR LIQUID BIOPSY MARKET PLAYERS
• 11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • FIGURE 36 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
  • 11.5.5 COMPETITIVE BENCHMARKING
  • TABLE 134 BIOPSY DEVICES MARKET: PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
  • TABLE 135 BIOPSY DEVICES MARKET-PRODUCT FOOTPRINT ANALYSIS OF COMPANIES FOR KEY PLAYERS
  • TABLE 136 BIOPSY DEVICES MARKET- REGIONAL FOOTPRINT ANALYSIS OF KEY COMPANIES
• 11.6 START-UP/SME EVALUATION MATRIX (2022)
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • FIGURE 37 BIOPSY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
  • 11.6.5 COMPETITIVE BENCHMARKING FOR START-UPS/SMES
  • TABLE 137 BIOPSY DEVICES MARKET: PRODUCT & REGIONAL FOOTPRINT ANALYSIS OF COMPANIES
  • TABLE 138 BIOPSY DEVICES MARKET-PRODUCT FOOTPRINT ANALYSIS OF COMPANIES FOR START-UP/SME PLAYERS
  • TABLE 139 BIOPSY DEVICES MARKET- REGIONAL FOOTPRINT ANALYSIS OF START-UP/SME COMPANIES
• 11.7 COMPETITIVE SCENARIOS AND TRENDS
  • TABLE 140 BIOPSY DEVICES MARKET: PRODUCT LAUNCHES (JANUARY 2020-AUGUST 2023)
  • TABLE 141 BIOPSY DEVICES MARKET: DEALS (JANUARY 2020-AUGUST 2023)
  • TABLE 142 BIOPSY DEVICES MARKET: OTHER DEVELOPMENTS (JANUARY 2020-AUGUST 2023)

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
• (Business overview, Products offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats)**
• 12.1.1 BECTON, DICKINSON AND COMPANY
• TABLE 143 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
• FIGURE 38 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
• 12.1.2 DEVICOR MEDICAL PRODUCTS, INC. (PART OF DANAHER CORPORATION)
• TABLE 144 DANAHER CORPORATION: BUSINESS OVERVIEW
• FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.3 B. BRAUN MELSUNGEN AG
• TABLE 145 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
• FIGURE 40 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
• 12.1.4 CARDINAL HEALTH, INC.
• TABLE 146 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
• FIGURE 41 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
• 12.1.5 HOLOGIC, INC.
• TABLE 147 HOLOGIC, INC.: BUSINESS OVERVIEW
• FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT (2022)
• 12.1.6 OLYMPUS CORPORATION
• TABLE 148 OLYMPUS CORPORATION: BUSINESS OVERVIEW
• FIGURE 43 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.7 BOSTON SCIENTIFIC CORPORATION
• TABLE 149 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
• FIGURE 44 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.8 FUJIFILM CORPORATION
• TABLE 150 FUJIFILM CORPORATION: BUSINESS OVERVIEW
• FIGURE 45 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2022)
• 12.1.9 MEDTRONIC PLC
• TABLE 151 MEDTRONIC PLC: BUSINESS OVERVIEW
• FIGURE 46 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
• 12.1.10 STRYKER CORPORATION
• TABLE 152 STRYKER CORPORATION: BUSINESS OVERVIEW
• FIGURE 47 STRYKER: COMPANY SNAPSHOT (2022)
• 12.1.11 COOK GROUP INCORPORATED
• TABLE 153 COOK GROUP INCORPORATED: BUSINESS OVERVIEW
• 12.1.12 ARGON MEDICAL DEVICES
• TABLE 154 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW
• 12.1.13 INRAD, INC.
• TABLE 155 INRAD, INC.: BUSINESS OVERVIEW
• 12.1.14 CONMED CORPORATION
• TABLE 156 CONMED CORPORATION: BUSINESS OVERVIEW
• 12.1.15 TELEFLEX INCORPORATED
• TABLE 157 TELEFLEX INCORPORATED.: BUSINESS OVERVIEW
• FIGURE 48 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
• 12.1.16 QIAGEN N.V.
• TABLE 158 QIAGEN N.V.: BUSINESS OVERVIEW
• FIGURE 49 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
• 12.1.17 THERMO FISHER SCIENTIFIC, INC.
• TABLE 159 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
• FIGURE 50 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
• 12.2 OTHER PLAYERS
  • 12.2.1 SUMMIT MEDICAL LLC
  • 12.2.2 HILL-ROM HOLDINGS, INC.
  • 12.2.3 GALLINI S.R.L
  • 12.2.4 TRANSMED7, LLC
  • 12.2.5 TSK LABORATORY INTERNATIONAL
  • 12.2.6 MERIT MEDICAL SYSTEMS, INC.
  • 12.2.7 DR. JAPAN CO., LTD.
  • 12.2.8 IZI MEDICAL PRODUCTS
  • 12.2.9 PLANMED OY
  • 12.2.10 ADVIN HEALTH CARE
  • 12.2.11 F. HOFFMANN-LA ROCHE LTD.
  • 12.2.12 BIO-RAD LABORATORIES, INC.
  • 12.2.13 ILLUMINA, INC.
• *Details on Business overview, Products offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

관련자료